Exploring the Potential of Quinoline-Containing Pyrazoline Derivatives as Antidepressant Agents: <i>In Vivo</i> and <i>In Silico</i> Studies.
- DOI
- 10.2174/0118715273408493260904055147
- Published
- 2026-09-09
- Container
- CNS Neurol Disord Drug Targets
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2174/0118715273408493260904055147,
title = {Exploring the Potential of Quinoline-Containing Pyrazoline Derivatives as Antidepressant Agents: \<i\>In Vivo\</i\> and \<i\>In Silico\</i\> Studies.},
author = {Sharma B and Chahat and Kumar P and Kumar A and Chawla PA.},
year = {2026},
journal = {CNS Neurol Disord Drug Targets},
doi = {10.2174/0118715273408493260904055147},
url = {https://doi.org/10.2174/0118715273408493260904055147}
}RIS
TY - JOUR TI - Exploring the Potential of Quinoline-Containing Pyrazoline Derivatives as Antidepressant Agents: <i>In Vivo</i> and <i>In Silico</i> Studies. AU - Sharma B AU - Chahat AU - Kumar P AU - Kumar A AU - Chawla PA. PY - 2026 JO - CNS Neurol Disord Drug Targets DO - 10.2174/0118715273408493260904055147 UR - https://doi.org/10.2174/0118715273408493260904055147 ER -
APA
B, S., Chahat, P, K., A, K., & PA., C. (2026). Exploring the Potential of Quinoline-Containing Pyrazoline Derivatives as Antidepressant Agents: <i>In Vivo</i> and <i>In Silico</i> Studies.. CNS Neurol Disord Drug Targets. https://doi.org/10.2174/0118715273408493260904055147
Source records
- europe-pmc · retrieved 2026-09-26T05:12:20.178Z